BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 18941414)

  • 1. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model.
    Nobre SR; Cabral JE; Gomes JJ; Leitão MC
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1176-81. PubMed ID: 18941414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].
    Wang X; Wang BM; Jiang K; Zhang J; Fang WL; Wang T; Li XY
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):629-32. PubMed ID: 19954052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between model for end-stage liver disease and spontaneous bacterial peritonitis.
    Obstein KL; Campbell MS; Reddy KR; Yang YX
    Am J Gastroenterol; 2007 Dec; 102(12):2732-6. PubMed ID: 17714556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.
    Luca A; Angermayr B; Bertolini G; Koenig F; Vizzini G; Ploner M; Peck-Radosavljevic M; Gridelli B; Bosch J
    Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.
    Khan R; Abid S; Jafri W; Awan S; Hamid S; Shah H; Pervez S
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications.
    Huo TI; Lin HC; Wu JC; Hou MC; Lee FY; Lee PC; Chang FY; Lee SD
    Clin Transplant; 2006; 20(2):188-94. PubMed ID: 16640525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM; Hwang SG; Park HH; Park JH; Kim HT; Oh SW; Kho KH; Hong SP; Park PW; Rim GS; Kim SH
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):98-106. PubMed ID: 12824749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.
    Serra MA; Puchades MJ; Rodríguez F; Escudero A; del Olmo JA; Wassel AH; Rodrigo JM
    Scand J Gastroenterol; 2004 Nov; 39(11):1149-53. PubMed ID: 15545175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS; Deisanti D; Seva-Pereira T; Almeida JR; Yamanaka A; Boin IF; Soares EC
    Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
    Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
    Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.